News Coverage 08.25.20 Share on Twitter Share on Facebook Share on LinkedIn The Parker Institute for Cancer Immunotherapy Appoints John Connolly, PhD, as Chief Scientific Officer Related Announcement, Press Release PICI Invests $1 Million+ in 5 Early Career Researchers Announcement, Patient Story Living Proof: Cancer Vaccine Recipients Bring Their Sto Research Update Cancer Vaccines: A New Era in Cancer Treatment